Clinical IT
July 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]
Read MoreOctober 2010 source: Medical Device & Diagnostic Industry online The MX Q&A: Ted Driscoll, Claremont Creek Ventures Fledgling device companies can get a leg up with VC firms by developing a product that is ‘unique and protectable,’ says Tibion’s anchor investor. The cofounders of Tibion Bionic Technologies may want to send a thank-you note to […]
Read MoreOctober 20, 2010 source: San Francisco Chronicle Business Report “With the help of a physical therapist, Micha Hoy strapped a big black computer-controlled device onto her left leg, which has had limited mobility since she experienced a stroke nine years ago. “I feel like I should be in the ‘Matrix’ movies,” the San Francisco architect […]
Read MoreFertility Patients Can Now Use One Screening for Multiple Types of Genetic Diseases Before Pregnancy
August 10, 2010 source: Send2Press Newswire DAVIS, Calif., Aug. 10 (SEND2PRESS NEWSWIRE) — California IVF: Davis Fertility Center, Inc. (californiaivf.com), working in conjunction with Gene Security Network (genesecurity.net) leads the field in bringing a new test to patients that combines the detection of single-gene genetic disorders with a 24 chromosome screening. Using Gene Security Network’s […]
Read MoreJuly 13, 2010 source: VentureBeat Tibion Bionic Technologies, a startup that develops orthopedic devices to help patients regain mobility, has closed a $3 million round of equity, according to a filing with the SEC. The company’s knee technologies can be used during physical therapy to help patients dealing with a stroke, multiple sclerosis, Parkinson’s disease […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.